These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 21495292)
1. [Angiotensin-converting enzyme inhibitors. Current indications]. Mitu F; Rădoi D Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):23-31. PubMed ID: 21495292 [TBL] [Abstract][Full Text] [Related]
2. Using ACE inhibitors appropriately. Bicket DP Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524 [TBL] [Abstract][Full Text] [Related]
3. Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease. Martin J; Krum H Pharmacol Res; 2002 Sep; 46(3):203-12. PubMed ID: 12220962 [TBL] [Abstract][Full Text] [Related]
5. Blocking the renin-angiotensin system: dual- versus mono-therapy. Ravandi A; Teo KK Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282 [TBL] [Abstract][Full Text] [Related]
6. Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted? Mansur SJ; Hage FG; Oparil S Curr Cardiol Rep; 2010 Nov; 12(6):450-63. PubMed ID: 20827517 [TBL] [Abstract][Full Text] [Related]
7. Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors? Shah AD; Arora RR Clin Cardiol; 2005 Dec; 28(12):551-5. PubMed ID: 16405197 [TBL] [Abstract][Full Text] [Related]
8. The clinical use of angiotensin-converting enzyme inhibitors. Wong J; Patel RA; Kowey PR Prog Cardiovasc Dis; 2004; 47(2):116-30. PubMed ID: 15586352 [TBL] [Abstract][Full Text] [Related]
9. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitors in cardiovascular and renal disease in Africans: a review. Ajayi AA Afr J Med Med Sci; 1991 Jun; 20(2):123-34. PubMed ID: 1908620 [TBL] [Abstract][Full Text] [Related]
11. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers]. Pichler M; Klein W; Huber K; Pachinger O Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease? Doggrell SA Expert Opin Pharmacother; 2002 Nov; 3(11):1543-56. PubMed ID: 12437489 [TBL] [Abstract][Full Text] [Related]
13. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues. Borghi C; ; Rossi F; High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596 [TBL] [Abstract][Full Text] [Related]
14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology. Leary AC; MacDonald TM Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blockers: novel role in high-risk patients. Javed U; Deedwania PC Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228 [TBL] [Abstract][Full Text] [Related]
17. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint]. Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518 [TBL] [Abstract][Full Text] [Related]
18. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?]. Karlsen FM; Kamper AL Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833 [No Abstract] [Full Text] [Related]
19. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects. Katragadda S; Arora RR Am J Ther; 2010; 17(1):e11-23. PubMed ID: 20090429 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Grothusen A; Divchev D; Luchtefeld M; Schieffer B Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]